AINUO Medical Laboratory

Services

Data-driven Testing, Treatment-empowered Care.

Company Overview

Wuhan AINUO Medical laboratory was established in November 2021, It is an independent third-party medical testing service organization, wholly invested and built by Amison, located in Wuhan Hi-Tech Medical Equipment Park

Business Scope

The medical inspection institute has a standard PCR laboratory and NGS laboratory, equipped with a first-class professional medical testing platform system and facilities. At present, the testing items that can be carried out include: early diagnosis and screening of tumors, genetic testing of infectious pathogens, etc.

Service purposes

The medical inspection institute will adhere to the quality goal of "customer-oriented, excellence, rigorous and honest, accurate and timely", and provide accurate and efficient medical testing services for individuals and medical institutions.

Product Display

Client First. Excellence Always. Precision Delivered.

Fecal Sample Collection and Preservation Tube

Registration Number: Hubei Hankou Medical Device Registration No. 20191654

Medical Device Advertisement Approval (Text): No. 271127-26511

Product Application: Suitable for auxiliary diagnosis in patients recommended by clinicians for colonoscopy examination

Product Introduction:

Feces are formed in the large intestine, and fecal samples contain a large number of exfoliated cells from the intestinal tract (approximately 1 billion intestinal epithelial cells are shed per day in adults). DNA from intestinal exfoliated cells can non-invasively, conveniently, and early reflect the health status of the intestinal tract.

Molecular markers of intestinal tumors/lesions are released into feces through an exfoliation mechanism, while entering the bloodstream through an invasion mechanism. This mechanism has a very low release rate in early tumors, so molecular signals obtained from feces are earlier compared to blood. Fecal DNA testing can more early and accurately reflect whether the intestinal tract has cancerous changes.

Detection Process

Intelligent Programs, Accurate Testing.

Sample Type

Blood

Tissue

Cells

Stool

Urine

About Us

Expertise in Action. Innovation in Progress. Accuracy in Every Test.

Wuhan Ainuo Medical Laboratory Co., Ltd. was established in November 2021. The company has a complete personnel structure and well-equipped facilities, having obtained multiple laboratory qualifications and currently conducting various testing projects.

The laboratory has established a comprehensive quality management system, strict operating procedures, and internal quality control mechanisms in accordance with ISO15189 standards. We have built a complete service process covering sampling guidance, sample packaging and mailing, sample reception, sample testing, report issuance, report interpretation, and patient follow-up, providing testing services for several well-known domestic health examination centers and testing institutions. The laboratory currently has a daily testing capacity of up to 3,000 samples. To further enhance testing quality and quality control capabilities, the laboratory actively participates in external quality assessment activities organized by clinical testing centers at various levels and has achieved perfect scores for several consecutive years.